Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

UV rays can cause a type of hair loss known as telogen alopecia.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.